![]() |
市場調查報告書
商品編碼
2085286
基因改造作物農業生物技術市場:按性狀類型、作物類型、技術平台、應用和最終用戶分類的全球市場預測 – 2026–2032Agricultural Biotechnology for Transgenic Crops Market by Trait Type, Crop Type, Technology Platform, Application, End User - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,基改作物的農業生技市場將成長至 23.8 億美元,複合年成長率為 8.89%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 13.1億美元 |
| 預計年份:2026年 | 14.2億美元 |
| 預測年份 2032 | 23.8億美元 |
| 複合年成長率 (%) | 8.89% |
基因改造作物的農業生物技術已從提高產量的手段發展成為支撐糧食安全、應對氣候變遷和提升農場盈利的重要戰略支柱。目前,商業性種植的基因改造作物主要集中在大豆、玉米、棉花和菜籽,其中除草劑抗性、抗蟲性和組合性狀是最廣泛應用的性狀類別。
基因改造作物的格局正從單一性狀種子產品轉向整合多性狀、先進育種技術、數位農藝、精準作物保護和永續性農場管理的綜合平台。市場需求與氣候變遷、抗除草劑雜草、不斷演變的病蟲害威脅、土壤和水資源限制以及在有限耕地上提高生產力的需求日益密切相關。
人工智慧正逐漸成為農業生物技術整體,特別是基改作物領域的累積驅動力。機器學習透過大規模分析基因組、田間、天氣、土壤、病蟲害和影像資料集,為基因功能發現、性狀優先排序、預測育種、高通量表現型分析、蛋白質和代謝路徑分析以及環境風險評估提供支援。
亞太地區基改作物的發展潛力大,但現況不一。在中國,國產基改玉米和大豆性狀的核准速度正在加速;在印度,Bt棉花的種植經驗豐富;在澳大利亞,商業化基改棉花和菜籽的種植在以科學為基礎的監管模式下得到支持。北美地區憑藉其完善的監管體系、先進的種子市場、強大的推廣支持網路以及農民對基改玉米、大豆、棉花、菜籽和苜蓿的高度認知,仍然是基改作物應用最成熟的地區之一。
東協為農業生物技術的發展提供了分散但巨大的機會。菲律賓和越南在批准基改作物方面已累積了豐富的經驗,但其他一些成員國仍出於對生物多樣性保護、貿易影響、小規模耕作模式以及消費者情緒的擔憂而保持謹慎。海灣合作理事會(GCC)國家不太重視基改作物的廣泛種植,而是專注於能夠支持具有韌性的食品供應鏈、確保進口穩定、在可控環境下生產以及在水資源短缺和耕地有限的情況下保障糧食安全的技術。
美國憑藉多年來基因改造玉米、大豆、棉花、菜籽、甜菜和苜蓿的商業化,仍然是大規模基因改造作物應用的標竿。另一方面,加拿大擁有強大的基改菜籽、玉米和大豆生產體系,並以科學評估為支持。墨西哥的特點是依賴進口、玉米政策爭議不斷、食品與飼料的區分以及生物安全審查嚴格。巴西擁有大規模的種植面積和完善的大豆、玉米和棉花批准體系,是世界上最重要的生物技術作物生產國之一。
產業領導者應優先考慮能夠應對農場實際挑戰的性狀組合,例如抗除草劑雜草、病蟲害、乾旱影響、產量穩定性、病害風險和投入效率。商業策略應整合優質種子遺傳資源、基因改造性狀、作物保護、數位化農藝、農民培訓以及能夠延緩抗藥性發展並增強種植者信心的管理方案。
本執行摘要基於三角測量法進行的二次調查和產業核實,所用資訊來源包括生物安全機構、美國農業部、美國農業部(USDA)、糧農組織統計資料庫(FAOSTAT)、經合組織(OECD)資料、國際農業生物技術應用服務組織(ISAAA)實施資料、同行評審文獻、監管通告、貿易文件和國際食品安全參考資料。本檢驗重點在於檢驗的實施模式、監管趨勢、技術趨勢、作物性狀的商業化現狀以及區域市場趨勢。
農業生物技術,特別是基改作物,仍然是提高生產力、增強作物韌性和保護作物安全的關鍵要素,尤其是在那些生物安全體系完善、農民接受度高、農業以出口為導向且監管流程以科學為基礎的地區。只有當監管清晰、農民需求旺盛、種子基礎設施完善、管理完善且貿易認可度高時,農業生物技術的發展勢頭才能達到最大化。
The Agricultural Biotechnology for Transgenic Crops Market is projected to grow by USD 2.38 billion at a CAGR of 8.89% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.31 billion |
| Estimated Year [2026] | USD 1.42 billion |
| Forecast Year [2032] | USD 2.38 billion |
| CAGR (%) | 8.89% |
Agricultural biotechnology for transgenic crops has evolved from a productivity tool into a strategic pillar of food security, climate resilience, and farm profitability. Commercial genetically modified crops remain concentrated in soybean, maize, cotton, and canola, with herbicide tolerance, insect resistance, and stacked traits representing the most widely adopted trait categories.
Verified industry evidence confirms the scale of adoption: ISAAA reported 190.4 million hectares of biotech crops planted across 29 countries in 2019, driven largely by farmer demand for yield protection, weed and pest control, input efficiency, and operational flexibility. The industry is increasingly shaped by seed innovation, trait licensing, biosafety regulation, export acceptance, stewardship practices, and evidence-based communication that supports public and regulatory confidence.
The transgenic crops landscape is shifting from single-trait seed products toward integrated platforms that combine stacked traits, advanced breeding, digital agronomy, precision crop protection, and sustainability-oriented farm management. Demand is increasingly linked to climate volatility, herbicide-resistant weeds, evolving insect pressure, soil and water constraints, and the need to improve productivity on limited arable land.
At the same time, regulatory divergence is reshaping commercialization strategy. North America and parts of Latin America generally support large-scale adoption through established biosafety frameworks, while the European Union remains restrictive on cultivation but dependent on imported biotech feed ingredients. Companies that align transgenic traits with resistance management, transparent safety data, sustainability claims, identity preservation, and market-access planning are better positioned to compete across export-sensitive agricultural value chains.
Artificial intelligence is becoming a cumulative accelerator across agricultural biotechnology for transgenic crops. Machine learning supports gene-function discovery, trait prioritization, predictive breeding, high-throughput phenotyping, protein and pathway analysis, and environmental risk assessment by analyzing genomic, field, weather, soil, pest, and imagery datasets at scale.
AI does not replace regulated field trials, molecular characterization, compositional analysis, food and feed safety assessment, or biosafety review; it improves the speed and quality of decisions before those costly stages. The strongest opportunities are in trait discovery, regulatory dossier preparation, resistance forecasting, seed placement, agronomic recommendations, and post-commercial stewardship, provided organizations maintain data governance, model validation, cybersecurity, and explainability for regulators, growers, and supply chain partners.
Asia-Pacific is a mixed but high-potential region for transgenic crops, with China accelerating approvals for domestic biotech corn and soybean traits, India maintaining broad experience with Bt cotton, and Australia supporting commercial biotech cotton and canola under a science-based regulatory model. North America remains one of the most mature adoption regions, supported by established regulatory systems, advanced seed markets, strong extension networks, and high farmer familiarity with genetically modified corn, soybean, cotton, canola, and alfalfa.
Latin America is a major global adoption center, led by Brazil and Argentina, where biotech soybean, maize, and cotton are deeply integrated into export-oriented agriculture and conservation farming systems. Europe remains restrictive for cultivation, especially within the European Union, but continues to authorize and import biotech soybean meal and other feed ingredients used by livestock industries. The Middle East is primarily a food-security and import-reliant region with limited commercial cultivation, where biotechnology relevance is tied to supply assurance, arid-land agriculture, and resilient food systems. Africa remains uneven but strategically important, with South Africa commercializing GM maize, soybean, and cotton, while Nigeria, Kenya, Ethiopia, and other countries continue strengthening biosafety frameworks, local research capacity, and public-sector crop innovation.
ASEAN presents a fragmented but important opportunity for agricultural biotechnology, as the Philippines and Vietnam have established experience with biotech crop approvals, while several other member states remain cautious due to biodiversity protection, trade exposure, smallholder structures, and consumer-sentiment considerations. The GCC is less focused on broad transgenic crop cultivation and more focused on resilient food supply chains, import assurance, controlled-environment production, and technologies that can support food security under water scarcity and limited arable land.
The European Union continues to influence global compliance through stringent GMO authorization, labeling, traceability, coexistence, and risk assessment requirements, affecting exporters that supply feed, food, and crop-derived ingredients into European markets. BRICS is strategically significant because Brazil, China, India, Russia, and South Africa collectively shape demand, production policy, biosafety regulation, and trade flows across major crop systems, despite different positions on cultivation and import approvals. G7 countries concentrate advanced R&D, intellectual property, regulatory science, food safety assessment, and trade influence, while NATO members add relevance through secure seed supply chains, agricultural biosecurity, food resilience, and protection of critical agri-food infrastructure.
The United States remains the benchmark for large-scale transgenic crop adoption, supported by long-standing commercialization of GM corn, soybean, cotton, canola, sugar beet, and alfalfa, while Canada has strong biotech canola, corn, and soybean systems backed by science-based assessment. Mexico is shaped by import dependence, corn policy debates, food-versus-feed distinctions, and biosafety scrutiny, while Brazil is one of the world's most important biotech crop producers, with large soybean, maize, and cotton acreage and an established approval framework.
In Europe, the United Kingdom is reassessing agricultural biotechnology policy after Brexit, with increasing attention to precision breeding and science-led regulation, while Germany, France, Italy, and Spain remain influenced by EU-level GMO rules, national cultivation positions, and consumer acceptance dynamics; Spain is notable for commercial cultivation of insect-resistant maize. Russia maintains restrictive positions on GMO cultivation and emphasizes domestic seed and food security objectives.
In Asia-Pacific, China is advancing domestic biotech seed commercialization for corn and soybean while continuing to manage import approvals for feed and processing needs. India remains led by Bt cotton, with broader food-crop biotechnology subject to regulatory and public debate. Japan and South Korea function primarily as major import approval and food safety assessment markets for biotech crop commodities, while Australia supports biotech cotton and canola through a science-based regulatory model and coexistence practices that support export-oriented agriculture.
Industry leaders should prioritize trait portfolios that address measurable farm problems, including herbicide-resistant weeds, insect pressure, drought exposure, yield stability, disease risk, and input efficiency. Commercial strategy should integrate elite seed genetics, transgenic traits, crop protection, digital agronomy, farmer training, and stewardship programs that delay resistance and strengthen grower trust.
Organizations should build regulatory intelligence early in product development, localize evidence for target markets, and maintain transparent communication on safety, sustainability, labeling, coexistence, and trade compatibility. Strategic partnerships with public research institutes, local seed developers, distributors, grower organizations, and AI technology providers can improve market access, reduce development risk, and support responsible deployment of biotech crop innovations.
This executive summary is based on triangulated secondary research and industry validation using publicly available sources, including biosafety authorities, agricultural ministries, USDA resources, FAOSTAT, OECD materials, ISAAA adoption data, peer-reviewed literature, regulatory filings, trade documentation, and international food safety references. The analysis emphasizes verifiable adoption patterns, regulatory signals, technology trends, crop-trait commercialization status, and regional market behavior.
The methodology applies qualitative and quantitative screening across crop type, trait category, geography, regulatory readiness, commercialization status, trade exposure, stewardship requirements, and technology impact. Findings were assessed for consistency across multiple credible sources, with unsupported market sizing, market share, and forecasting claims excluded to maintain accuracy and relevance.
Agricultural biotechnology for transgenic crops remains a critical enabler of productivity, resilience, and crop protection, particularly in regions with established biosafety systems, farmer adoption experience, export-oriented agriculture, and science-based regulatory pathways. Momentum will be strongest where regulatory clarity, farmer demand, seed infrastructure, stewardship discipline, and trade acceptance converge.
The next competitive phase will be defined by stacked traits, AI-assisted discovery, precision stewardship, localized regulatory evidence, and transparent safety communication. Organizations that combine scientific credibility with disciplined commercialization and market-specific execution will be best positioned to create long-term value across the global transgenic crops ecosystem.